Luye Pharma Group Ltd. (2186.HK)
HKD 2.17
(-2.25%)
HKD 2.17
(-2.25%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.22 Billion CNY | 42.54% |
| 2022 | 2.26 Billion CNY | -46.43% |
| 2021 | 4.22 Billion CNY | -2.56% |
| 2020 | 4.33 Billion CNY | 5.25% |
| 2019 | 4.12 Billion CNY | 386.35% |
| 2018 | 847.59 Million CNY | 365243.1% |
| 2017 | 232 Thousand CNY | -37.63% |
| 2016 | 372 Thousand CNY | -24.54% |
| 2015 | 493 Thousand CNY | -22.73% |
| 2014 | 638 Thousand CNY | -93.2% |
| 2013 | 9.38 Million CNY | -62.33% |
| 2012 | 24.91 Million CNY | 1145.9% |
| 2011 | 2 Million CNY | 51.75% |
| 2010 | 1.31 Million CNY | -95.61% |
| 2009 | 30 Million CNY | -59.96% |
| 2008 | 74.92 Million CNY | -35.29% |
| 2007 | 115.78 Million CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | -100.0% |
| 2004 | 8 Million CNY | -78.38% |
| 2003 | 37 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 2.73 Billion CNY | -13.91% |
| 2024 Q2 | 2.73 Billion CNY | 0.0% |
| 2023 Q3 | 3.22 Billion CNY | 53.18% |
| 2023 Q2 | 2.1 Billion CNY | 0.0% |
| 2023 Q1 | 2.1 Billion CNY | -6.94% |
| 2023 FY | 3.22 Billion CNY | 42.54% |
| 2023 Q4 | 3.22 Billion CNY | 0.0% |
| 2022 Q3 | 2.26 Billion CNY | -40.01% |
| 2022 Q2 | 3.77 Billion CNY | 0.0% |
| 2022 Q1 | 3.77 Billion CNY | -10.7% |
| 2022 FY | 2.26 Billion CNY | -46.43% |
| 2022 Q4 | 2.26 Billion CNY | 0.0% |
| 2021 Q3 | 4.22 Billion CNY | -0.4% |
| 2021 Q4 | 4.22 Billion CNY | 0.0% |
| 2021 Q1 | 4.24 Billion CNY | -2.17% |
| 2021 Q2 | 4.24 Billion CNY | 0.0% |
| 2021 FY | 4.22 Billion CNY | -2.56% |
| 2020 Q4 | 4.33 Billion CNY | 0.0% |
| 2020 Q1 | 4.58 Billion CNY | 11.18% |
| 2020 FY | 4.33 Billion CNY | 5.25% |
| 2020 Q3 | 4.33 Billion CNY | -5.34% |
| 2020 Q2 | 4.58 Billion CNY | 0.0% |
| 2019 Q3 | 4.51 Billion CNY | 136.57% |
| 2019 FY | 4.12 Billion CNY | 386.35% |
| 2019 Q1 | 1.9 Billion CNY | 124.93% |
| 2019 Q2 | 1.9 Billion CNY | 0.0% |
| 2019 Q4 | 4.12 Billion CNY | -8.6% |
| 2018 Q2 | 157 Thousand CNY | 0.0% |
| 2018 Q1 | 157 Thousand CNY | -32.33% |
| 2018 Q3 | 847.59 Million CNY | 539770.06% |
| 2018 Q4 | 847.59 Million CNY | 0.0% |
| 2018 FY | 847.59 Million CNY | 365243.1% |
| 2017 Q2 | 307 Thousand CNY | 0.0% |
| 2017 FY | 232 Thousand CNY | -37.63% |
| 2017 Q4 | 232 Thousand CNY | 0.0% |
| 2017 Q3 | 232 Thousand CNY | -24.43% |
| 2017 Q1 | 307 Thousand CNY | -17.47% |
| 2016 Q2 | 455 Thousand CNY | 0.0% |
| 2016 Q3 | 372 Thousand CNY | -18.24% |
| 2016 Q4 | 372 Thousand CNY | 0.0% |
| 2016 FY | 372 Thousand CNY | -24.54% |
| 2016 Q1 | 455 Thousand CNY | -7.71% |
| 2015 Q4 | 493 Thousand CNY | 0.0% |
| 2015 Q3 | 493 Thousand CNY | -11.65% |
| 2015 Q2 | 558 Thousand CNY | 0.0% |
| 2015 Q1 | 558 Thousand CNY | -12.54% |
| 2015 FY | 493 Thousand CNY | -22.73% |
| 2014 FY | 638 Thousand CNY | -93.2% |
| 2014 Q2 | 759 Thousand CNY | 0.0% |
| 2014 Q1 | 759 Thousand CNY | -91.91% |
| 2014 Q3 | 638 Thousand CNY | -15.94% |
| 2014 Q4 | 638 Thousand CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 FY | 9.38 Million CNY | -62.33% |
| 2013 Q4 | 9.38 Million CNY | 0.0% |
| 2013 Q3 | 9.38 Million CNY | 0.0% |
| 2012 Q1 | 3.93 Million CNY | 96.7% |
| 2012 Q2 | 48.44 Million CNY | 1131.47% |
| 2012 FY | 24.91 Million CNY | 1145.9% |
| 2011 Q2 | 1.27 Million CNY | -2.15% |
| 2011 FY | 2 Million CNY | 51.75% |
| 2011 Q3 | 1.15 Million CNY | -9.04% |
| 2011 Q4 | 2 Million CNY | 72.86% |
| 2011 Q1 | 1.3 Million CNY | -1.37% |
| 2010 Q1 | - CNY | -100.0% |
| 2010 FY | 1.31 Million CNY | -95.61% |
| 2010 Q4 | 1.31 Million CNY | -12.07% |
| 2010 Q3 | 1.49 Million CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2009 FY | 30 Million CNY | -59.96% |
| 2009 Q4 | 30 Million CNY | 0.0% |
| 2008 FY | 74.92 Million CNY | -35.29% |
| 2007 FY | 115.78 Million CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | -100.0% |
| 2004 FY | 8 Million CNY | -78.38% |
| 2003 FY | 37 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 107.05 Million HKD | -2915.368% |